EUVIMEDEUVIMED entdecken
Open Access

Cell Therapy from Bench to Bedside Translation in CNS Neurorestoratology Era

Hongyun Huang, Lin Chen, Paul Sanberg

Cell Medicine · 2010

DOI: 10.3727/215517910x516673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Medicine, 2010. Verfasst von Hongyun Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neurorestoratology, Beijing Rehabilitation Center, Beijing, P.R. China. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 429 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in cell biology, neural injury and repair, and the progress towards development of neurorestorative interventions are the basis for increased optimism. Based on the complexity of the processes of demyelination and remyelination, degeneration and regeneration, damage and repair, functional loss and recovery, it would be expected that effective therapeutic approaches will require a combination of strategies encompassing neuroplasticity, immunomodulation, neuroprotection, neurorepair, neuroreplacement, and neuromodulation. Cell-based restorative treatment has become a new trend, and increasing data worldwide have strongly proven that it has a pivotal therapeutic value in CNS disease. Moreover, functional neurorestoration has been achieved to a certain extent in the CNS clinically. Up to now, the cells successfully used in preclinical experiments and/or clinical trial/treatment include fetal/embryonic brain and spinal cord tissue, stem cells (embryonic stem cells, neural stem/progenitor cells, hematopoietic stem cells, adipose-derived adult stem/precursor cells, skin-derived precursor, induced pluripotent stem cells), glial cells (Schwann cells, oligodendrocyte, olfactory ensheathing cells, astrocytes, microglia, tanycytes), neuronal cells (various phenotypic neurons and Purkinje cells), mesenchymal stromal cells originating from bone marrow, umbilical cord, and umbilical cord blood, epithelial cells derived from the layer of retina and amnion, menstrual blood-derived stem cells, Sertoli cells, and active macrophages, etc. Proof-of-concept indicates that we have now entered a new era in neurorestoratology.

Autor:innen und Institutionen

  • Center for Neurorestoratology, Beijing Rehabilitation Center, Beijing, P.R. China.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Huang, H., Chen, L., & Sanberg, P. (2010). Cell Therapy from Bench to Bedside Translation in CNS Neurorestoratology Era. Cell Medicine. https://doi.org/10.3727/215517910x516673

Vancouver

Huang H, Chen L, Sanberg P. Cell Therapy from Bench to Bedside Translation in CNS Neurorestoratology Era. Cell Medicine. 2010. doi:10.3727/215517910x516673

BibTeX
@article{Huang2010,
  author = {Huang, Hongyun and Chen, Lin and Sanberg, Paul},
  title = {Cell Therapy from Bench to Bedside Translation in CNS Neurorestoratology Era},
  journal = {Cell Medicine},
  year = {2010},
  doi = {10.3727/215517910x516673}
}
Kostenlos starten →